KEGG   PATHWAY: plai04370
Entry
plai04370                   Pathway                                
Name
VEGF signaling pathway - Poecilia latipinna (sailfin molly)
Description
There is now much evidence that VEGFR-2 is the major mediator of VEGF-driven responses in endothelial cells and it is considered to be a crucial signal transducer in both physiologic and pathologic angiogenesis. The binding of VEGF to VEGFR-2 leads to a cascade of different signaling pathways, resulting in the up-regulation of genes involved in mediating the proliferation and migration of endothelial cells and promoting their survival and vascular permeability. For example, the binding of VEGF to VEGFR-2 leads to dimerization of the receptor, followed by intracellular activation of the PLCgamma;PKC-Raf kinase-MEK-mitogen-activated protein kinase (MAPK) pathway and subsequent initiation of DNA synthesis and cell growth, whereas activation of the phosphatidylinositol 3' -kinase (PI3K)-Akt pathway leads to increased endothelial-cell survival. Activation of PI3K, FAK, and p38 MAPK is implicated in cell migration signaling.
Class
Environmental Information Processing; Signal transduction
Pathway map
plai04370  VEGF signaling pathway
plai04370

Other DBs
GO: 0048010
Organism
Poecilia latipinna (sailfin molly) [GN:plai]
Gene
106934590  [KO:K00922] [EC:2.7.1.153]
106934781  ppp3r1; calcineurin subunit B type 1 [KO:K06268]
106935202  [KO:K02649]
106935328  pla2g4c; cytosolic phospholipase A2 gamma [KO:K16342] [EC:3.1.1.4]
106935770  [KO:K07827]
106936155  pla2g4a; cytosolic phospholipase A2 [KO:K16342] [EC:3.1.1.4]
106936158  ptgs2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
106936613  plcg2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
106937578  [KO:K01116] [EC:3.1.4.11]
106938139  [KO:K04441] [EC:2.7.11.24]
106938218  [KO:K02649]
106938420  [KO:K19663] [EC:2.7.11.13]
106938435  pik3r3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
106939249  [KO:K04718] [EC:2.7.1.91]
106939953  [KO:K19662] [EC:2.7.11.13]
106940345  plcg1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [KO:K01116] [EC:3.1.4.11]
106941461  [KO:K02649]
106943350  [KO:K04441] [EC:2.7.11.24]
106943627  [KO:K04441] [EC:2.7.11.24]
106944581  [KO:K05760]
106946032  [KO:K00922] [EC:2.7.1.153]
106947041  [KO:K04348] [EC:3.1.3.16]
106947050  hspb1; heat shock protein beta-1 [KO:K04455]
106947213  [KO:K02649]
106947478  mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
106947619  prkcb; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
106947659  [KO:K04441] [EC:2.7.11.24]
106947839  [KO:K04441] [EC:2.7.11.24]
106947864  shc2; SHC-transforming protein 2 [KO:K17447]
106948092  raf1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
106948309  bad; bcl2-associated agonist of cell death isoform X1 [KO:K02158]
106949471  pik3cd; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
106950524  vegfb; vascular endothelial growth factor B isoform X1 [KO:K05448]
106950841  sphk1; sphingosine kinase 1 [KO:K04718] [EC:2.7.1.91]
106951123  [KO:K04393]
106951125  [KO:K04393]
106951627  [KO:K07827]
106952116  [KO:K04348] [EC:3.1.3.16]
106952231  [KO:K04393]
106952393  [KO:K04348] [EC:3.1.3.16]
106953261  [KO:K04444] [EC:2.7.11.1]
106953407  [KO:K07860]
106953505  [KO:K04718] [EC:2.7.1.91]
106953637  akt1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
106953713  hras; GTPase HRas [KO:K02833]
106954128  [KO:K04393]
106954316  [KO:K02649]
106954618  [KO:K05704] [EC:2.7.10.2]
106954620  [KO:K17332]
106955117  [KO:K04441] [EC:2.7.11.24]
106955889  [KO:K04441] [EC:2.7.11.24]
106956367  map2k1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
106956478  vegfa; vascular endothelial growth factor A isoform X1 [KO:K05448]
106956787  pik3cb; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
106956979  [KO:K05760]
106957004  [KO:K04392]
106957043  [KO:K02677] [EC:2.7.11.13]
106957058  [KO:K04718] [EC:2.7.1.91]
106957375  [KO:K04456] [EC:2.7.11.1]
106957385  prkca; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
106957415  [KO:K04371] [EC:2.7.11.24]
106958310  mapkapk2; MAP kinase-activated protein kinase 2 [KO:K04443] [EC:2.7.11.1]
106958420  [KO:K04444] [EC:2.7.11.1]
106958666  [KO:K04348] [EC:3.1.3.16]
106959224  map2k2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
106960237  [KO:K05704] [EC:2.7.10.2]
106960253  [KO:K17332]
106960438  ptk2; focal adhesion kinase 1 isoform X1 [KO:K05725] [EC:2.7.10.2]
106960475  [KO:K04441] [EC:2.7.11.24]
106961120  [KO:K17332]
106961755  [KO:K04392]
106961760  [KO:K04392]
106961762  [KO:K04392]
106961773  [KO:K04392]
106962003  [KO:K00922] [EC:2.7.1.153]
106962362  akt3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
106962762  rac3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
106963026  casp9; caspase-9 [KO:K04399] [EC:3.4.22.62]
106963298  [KO:K04455]
106963463  kdr; vascular endothelial growth factor receptor 2 isoform X1 [KO:K05098] [EC:2.7.10.1]
106964331  [KO:K06268]
106964589  [KO:K04456] [EC:2.7.11.1]
106964683  [KO:K04393]
106965285  [KO:K04348] [EC:3.1.3.16]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C00533  Nitric oxide
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01312  Prostaglandin I2
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L.
  Title
VEGF-receptor signal transduction.
  Journal
Trends Biochem Sci 28:488-94 (2003)
DOI:10.1016/S0968-0004(03)00193-2
Reference
  Authors
Matsumoto T, Claesson-Welsh L.
  Title
VEGF receptor signal transduction.
  Journal
Sci STKE 2001:RE21 (2001)
DOI:10.1126/stke.2001.112.re21
Reference
  Authors
Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA.
  Title
Vascular endothelial growth factor and angiogenesis.
  Journal
Pharmacol Rev 56:549-80 (2004)
DOI:10.1124/pr.56.4.3
Reference
  Authors
Takahashi H, Shibuya M.
  Title
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.
  Journal
Clin Sci (Lond) 109:227-41 (2005)
DOI:10.1042/CS20040370
Reference
  Authors
Zachary I.
  Title
VEGF signalling: integration and multi-tasking in endothelial cell biology.
  Journal
Biochem Soc Trans 31:1171-7 (2003)
DOI:10.1042/bst0311171
Reference
  Authors
Munoz-Chapuli R, Quesada AR, Angel Medina M.
  Title
Angiogenesis and signal transduction in endothelial cells.
  Journal
Cell Mol Life Sci 61:2224-43 (2004)
DOI:10.1007/s00018-004-4070-7
Reference
  Authors
Lamalice L, Houle F, Jourdan G, Huot J.
  Title
Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38.
  Journal
Oncogene 23:434-45 (2004)
DOI:10.1038/sj.onc.1207034
Reference
  Authors
Shu X, Wu W, Mosteller RD, Broek D.
  Title
Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases.
  Journal
Mol Cell Biol 22:7758-68 (2002)
DOI:10.1128/MCB.22.22.7758-7768.2002
Related
pathway
plai00590  Arachidonic acid metabolism
plai04010  MAPK signaling pathway
plai04020  Calcium signaling pathway
plai04510  Focal adhesion
KO pathway
ko04370   

DBGET integrated database retrieval system